Valion Bio, Inc.: announces new board chair Thomas Jensen

What happened On Oct 5, 2026, Valion Bio, Inc. issued a press release highlighting the expertise and goals of new board chair Thomas Jensen as relating to the future of the company. The company filed a Current Report on Form 8-K on Oct 6, 2026 reporting this under Item 8.01 (Other events).

Key details

• Press release date: Oct 5, 2026.
• New board chair: Thomas Jensen.
• Report filed: Current Report on Form 8-K, filed Oct 6, 2026, under Item 8.01 (Other events).
• The filing and attached materials include forward-looking statements.

Why it may matter This filing was made under Item 8.01, which covers other events the company reports outside specific disclosure categories; here the company reported issuing a press release about its new board chair. The filing states that it contains forward-looking statements and identifies general risks that could cause actual results to differ. A filing does not show why the insider traded or why the company acted.